Ciana Therapeutics Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Ciana Therapeutics General Information
Description
Developer of novel drug therapies designed to focus on diabetic retinopathy. The company's therapies are based on a novel treatment that stabilizes and protects retinal capillaries from structural breakdown and prevents vascular leakage and retinal edema, enabling patients to combat vision loss and blindness in diabetes.
Contact Information
Website
www.cianatx.comCorporate Office
- Ved Hegnet 2
- 2960 Rungsted Kyst
- Denmark
Corporate Office
- Ved Hegnet 2
- 2960 Rungsted Kyst
- Denmark
Ciana Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 26-Apr-2026 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | 22-Sep-2020 | Completed | Generating Revenue |
Ciana Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ciana Therapeutics FAQs
-
When was Ciana Therapeutics founded?
Ciana Therapeutics was founded in 2019.
-
Where is Ciana Therapeutics headquartered?
Ciana Therapeutics is headquartered in Rungsted Kyst, Denmark.
-
What industry is Ciana Therapeutics in?
Ciana Therapeutics’s primary industry is Drug Discovery.
-
Is Ciana Therapeutics a private or public company?
Ciana Therapeutics is a Private company.
-
What is Ciana Therapeutics’s current revenue?
The current revenue for Ciana Therapeutics is .
-
How much funding has Ciana Therapeutics raised over time?
Ciana Therapeutics has raised $1.54M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
